Table 3 Skin-transport parameter obtained for various test formulations (Mean ± SD)
From: Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis
Formulation | Flux (μg /cm− 2 h− 1) | PC0 × 10–3 a | Cumulative drug skin-permeation (%) | Amount retained in skin (μg/cm2) |
|---|---|---|---|---|
TQ EV | 11.25 ± 1.05 | 15.78 ± 2.01 | 36.62 ± 2.01 | 88.71 ± 3.02 |
TQ suspension | 1.08 ± 0.01 | 8.00 ± 1.01 | 11.60 ± 1.07 | 72.86 ± 3.01 |